Metabolome-Genome-Wide Association Study (mGWAS) Reveals Novel Metabolites Associated with Future Type 2 Diabetes Risk and Susceptibility Loci in a Case-Control Study in a Chinese Prospective Cohort

Overview

Journal Glob Chall

Date 2021 Apr 15

PMID 33854788

Citations 10

Authors

Yang Ouyang

Gaokun Qiu

Xinjie Zhao

Benzhe Su

Disheng Feng

Wangjie Lv

Qiuhui Xuan

Lichao Wang

Di Yu

Qingqing Wang

Xiaohui Lin

Tangchun Wu

Guowang Xu

Affiliations

Soon will be listed here.

Abstract

In a Chinese prospective cohort, 500 patients with new-onset type 2 diabetes (T2D) within 4.61 years and 500 matched healthy participants are selected as case and control groups, and randomized into discovery and validation sets to discover the metabolite changes before T2D onset and the related diabetogenic loci. A serum metabolomics analysis reveals that 81 metabolites changed significantly before T2D onset. Based on binary logistic regression, eight metabolites are defined as a biomarker panel for T2D prediction. Pipecolinic acid, carnitine C14:0, epinephrine and phosphatidylethanolamine 34:2 are first found associated with future T2D. The addition of the biomarker panel to the clinical markers (BMI, triglycerides, and fasting glucose) significantly improves the predictive ability in the discovery and validation sets, respectively. By associating metabolomics with genomics, a significant correlation ( < 5.0 × 10) between eicosatetraenoic acid and the FADS1 (rs174559) gene is observed, and suggestive correlations ( < 5.0 × 10) between pipecolinic acid and CHRM3 (rs535514), and leucine/isoleucine and WWOX (rs72487966) are discovered. Elevated leucine/isoleucine levels increased the risk of T2D. In conclusion, multiple metabolic dysregulations are observed to occur before T2D onset, and the new biomarker panel can help to predict T2D risk.

Citing Articles

Genetic mapping of serum metabolome to chronic diseases among Han Chinese.

Cheng C, Xu F, Pan X, Wang C, Fan J, Yang Y Cell Genom. 2025; 5(2):100743.

PMID: 39837327 PMC: 11872534. DOI: 10.1016/j.xgen.2024.100743.

Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients.

Liu Y, Liu J, He H, Qin M, Lei H, Meng J Cardiovasc Diabetol. 2024; 23(1):14.

PMID: 38184583 PMC: 10771670. DOI: 10.1186/s12933-023-02102-0.

Effects of continuous intravenous infusion with propofol on intestinal metabolites in rats.

Li J, Zhang Z, Liu H, Qu X, Yin X, Chen L Biomed Rep. 2024; 20(2):25.

PMID: 38169795 PMC: 10758916. DOI: 10.3892/br.2023.1713.

Nontargeted Metabolomics Revealed Novel Association Between Serum Metabolites and Incident Acute Coronary Syndrome: A Mendelian Randomization Study.

Qiu G, Lin Y, Ouyang Y, You M, Zhao X, Wang H J Am Heart Assoc. 2023; 12(13):e028540.

PMID: 37382146 PMC: 10356091. DOI: 10.1161/JAHA.122.028540.

A Strategy for Uncovering the Serum Metabolome by Direct-Infusion High-Resolution Mass Spectrometry.

Sun X, Jia Z, Zhang Y, Zhao X, Zhao C, Lu X Metabolites. 2023; 13(3).

PMID: 36984900 PMC: 10057860. DOI: 10.3390/metabo13030460.

References

Sun L, Liang L, Gao X, Zhang H, Yao P, Hu Y . Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study. Diabetes Care. 2016; 39(9):1563-70. DOI: 10.2337/dc16-0232. View

Drogan D, Dunn W, Lin W, Buijsse B, Schulze M, Langenberg C . Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. Clin Chem. 2014; 61(3):487-97. DOI: 10.1373/clinchem.2014.228965. View

Lv Z, Ma P, Luo W, Xiong H, Han L, Li S . Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction. BMC Cardiovasc Disord. 2014; 14:159. PMC: 4236447. DOI: 10.1186/1471-2261-14-159. View

Wang-Sattler R, Yu Z, Herder C, Messias A, Floegel A, He Y . Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. 2012; 8:615. PMC: 3472689. DOI: 10.1038/msb.2012.43. View

Saeed A, Sharov V, White J, Li J, Liang W, Bhagabati N . TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003; 34(2):374-8. DOI: 10.2144/03342mt01. View

Aguer C, McCoin C, Knotts T, Thrush A, Ono-Moore K, McPherson R . Acylcarnitines: potential implications for skeletal muscle insulin resistance. FASEB J. 2014; 29(1):336-45. PMC: 4285541. DOI: 10.1096/fj.14-255901. View

Renuka T, Ani D, Paulose C . Alterations in the muscarinic M1 and M3 receptor gene expression in the brain stem during pancreatic regeneration and insulin secretion in weanling rats. Life Sci. 2004; 75(19):2269-80. DOI: 10.1016/j.lfs.2004.03.034. View

Fujita H, Hara K, Shojima N, Horikoshi M, Iwata M, Hirota Y . Variations with modest effects have an important role in the genetic background of type 2 diabetes and diabetes-related traits. J Hum Genet. 2012; 57(12):776-9. DOI: 10.1038/jhg.2012.110. View

Ashcroft F, Rorsman P . Diabetes mellitus and the β cell: the last ten years. Cell. 2012; 148(6):1160-71. PMC: 5890906. DOI: 10.1016/j.cell.2012.02.010. View

10.

Yamada C, Kondo M, Kishimoto N, Shibata T, Nagai Y, Imanishi T . Association between insulin resistance and plasma amino acid profile in non-diabetic Japanese subjects. J Diabetes Investig. 2015; 6(4):408-15. PMC: 4511300. DOI: 10.1111/jdi.12323. View

11.

Ingelsson E, Langenberg C, Hivert M, Prokopenko I, Lyssenko V, Dupuis J . Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes. 2010; 59(5):1266-75. PMC: 2857908. DOI: 10.2337/db09-1568. View

12.

Qiu G, Zheng Y, Wang H, Sun J, Ma H, Xiao Y . Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults. Int J Epidemiol. 2016; 45(5):1507-1516. DOI: 10.1093/ije/dyw221. View

13.

Dungan K, Buse J, Largay J, Kelly M, Button E, Kato S . 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006; 29(6):1214-9. DOI: 10.2337/dc06-1910. View

14.

Guo Y, Traurig M, Ma L, Kobes S, Harper I, Infante A . CHRM3 gene variation is associated with decreased acute insulin secretion and increased risk for early-onset type 2 diabetes in Pima Indians. Diabetes. 2006; 55(12):3625-9. DOI: 10.2337/db06-0379. View

15.

Mihalik S, Goodpaster B, Kelley D, Chace D, Vockley J, Toledo F . Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring). 2010; 18(9):1695-700. PMC: 3984458. DOI: 10.1038/oby.2009.510. View

16.

Corydon M, Andresen B, Bross P, Kjeldsen M, Andreasen P, Eiberg H . Structural organization of the human short-chain acyl-CoA dehydrogenase gene. Mamm Genome. 1997; 8(12):922-6. DOI: 10.1007/s003359900612. View

17.

Luo P, Yin P, Hua R, Tan Y, Li Z, Qiu G . A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology. 2017; 67(2):662-675. PMC: 6680350. DOI: 10.1002/hep.29561. View

18.

Ouyang Y, Tong H, Luo P, Kong H, Xu Z, Yin P . A high throughput metabolomics method and its application in female serum samples in a normal menstrual cycle based on liquid chromatography-mass spectrometry. Talanta. 2018; 185:483-490. DOI: 10.1016/j.talanta.2018.03.087. View

19.

Wang F, Zhu J, Yao P, Li X, He M, Liu Y . Cohort Profile: the Dongfeng-Tongji cohort study of retired workers. Int J Epidemiol. 2012; 42(3):731-40. DOI: 10.1093/ije/dys053. View

20.

Ouyang Y, Qiu G, Zhao X, Su B, Feng D, Lv W . Metabolome-Genome-Wide Association Study (mGWAS) Reveals Novel Metabolites Associated with Future Type 2 Diabetes Risk and Susceptibility Loci in a Case-Control Study in a Chinese Prospective Cohort. Glob Chall. 2021; 5(4):2000088. PMC: 8025395. DOI: 10.1002/gch2.202000088. View